Cooperative Agreement to Support an Evidence-based Clinical Practice Guideline for the Prescribing of Benzodiazepines

The U. S. Food and Drug Administration (FDA) seeks applications to develop, disseminate, implement, and evaluate an evidence-based Clinical Practice Guideline (CPG) for the safe tapering of benzodiazepines.

Applicants must propose a comprehensive evidence-based plan that advances safe tapering

credit:


of benzodiazepines.
Related Programs

Food and Drug Administration_Research

Department of Health and Human Services


Agency: Department of Health and Human Services

Office: Food and Drug Administration

Estimated Funding: $4,420,000


Who's Eligible


Relevant Nonprofit Program Categories





Obtain Full Opportunity Text:
FULL ANNOUNCEMENT

Additional Information of Eligibility:
This program provides all 50 states, the District of Columbia, 2 American Indian Tribes, 5 U. S. Territories, and 3 Freely Associated States as identified in the authorizing statute with funding to address their own unique public health needs and challenges with innovative and locally defined methods.

Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-FD-22-027.html

Contact:


Agency Email Description:
shashi.malhotra@fda.hhs.gov

Agency Email:


Date Posted:
2022-06-01

Application Due Date:


Archive Date:
2022-09-02


Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.






More Federal Domestic Assistance Programs


Puget Sound Action Agenda Outreach, Education and Stewardship Support Program | Special Education Grants to States, Recovery Act | Hurricane Sandy Community Development Block Grant Disaster Recovery Grants (CDBG-DR) | National Wildlife Refuge Fund | National Fire Academy Training Assistance |  Site Style by YAML | Grants.gov | Grants | Grants News | Sitemap | Privacy Policy


Edited by: Michael Saunders

© 2004-2024 Copyright Michael Saunders